Bioflavonoids: benefits, dosage, contraindications

Mis à jour le

Bioflavonoids, also known as vitamin P, are a group of compounds synthesized by plants with powerful antioxidant properties, found abundantly in a variety of fruits and vegetables, particularly in citrus fruits such as oranges, lemons, and grapefruits. These compounds include hesperidin, naringin, and rutin, which are mainly extracted from citrus peels and pulps. Discovered in the 1930s by the Hungarian scientist Albert Szent-Györgyi, bioflavonoids were initially recognized for their ability to strengthen the walls of blood vessels, hence their designation as "vitamin P" for their action on vascular permeability. Scientific research has since highlighted a multitude of benefits associated with these compounds, notably their role in preventing cardiovascular disease, thanks to their antioxidant effect which helps protect against damage caused by free radicals. Bioflavonoids are also being studied for their potential beneficial effects against various pathologies, such as cancer and inflammatory disorders, due to their anti-inflammatory activity and antimicrobial. Furthermore, clinical research has validated their ability to improve cardiovascular health by reducing the oxidation of LDL cholesterol, a key factor in the development of atherosclerosis. This action is attributed to the molecular structure of bioflavonoids, which allows them to effectively neutralize free radicals and favorably modulate lipid metabolism.

Other name(s) 

Vitamin P, flavonoids

Scientific name(s)

Citrus flavonoids

Family or group: 

Phytochemicals

Active ingredients:

Hesperidin

Rutin

Naringin


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Atherosclerosis
✪✪✪✪✪

Citrus bioflavonoids, such as hesperidin, naringin, and naringenin, play a crucial role in the prevention of atherosclerosis; they act mainly through their antioxidant capacity, helping to protect against oxidative damage, which is a key factor in the development of atherosclerosis. Hesperidin, in particular, has shown significant beneficial effects in reducing triglycerides and LDL cholesterol in hyperlipidemic patients, which is critical for lowering the risk of cardiovascular disease and atherosclerosis. Clinical studies have demonstrated that daily hesperidin supplementation can improve endothelial function and reduce blood pressure, thereby decreasing risk factors for atherosclerosis. A clinical trial investigated the efficacy of a bergamot polyphenol-enriched extract (BPE-C) in patients with metabolic syndrome. The double-blind study included obese patients with a plasma atherogenic index (AIP) greater than 0.34 and mild hyperglycemia. They were randomly assigned to receive two different doses of BPE-C (650 mg and 1300 mg per day) or a placebo for 90 days. Results indicated that treatment with BPE-C at the higher dose led to a significant reduction in fasting blood glucose, triglycerides, and cholesterol parameters, with decreases of up to 41.4% for LDL-C. This intervention also produced a notable reduction in AIP, falling well below the 0.2 threshold, indicating a decreased risk of atherosclerosis. The observed effects were dose-dependent and accompanied by improvements in insulin resistance and insulin levels.

Posologie

posologieOrally

posologie1300 mg


Venous insufficiency
✪✪✪✪✪

Bioflavonoids, particularly hesperidin, play a significant role in the treatment of venous insufficiency by reducing associated symptoms such as pain, edema, and thrombotic complications. In a prospective randomized study, the use of a combination of diosmin, troxerutin and hesperidin was evaluated in patients suffering from acute hemorrhoidal attacks. The results showed a significant improvement in symptoms, with a decrease in pain and edema, as well as a reduction in the persistence of thromboses in treated patients compared with a placebo group. This study involved 134 patients, with a treatment period of up to 12 days, followed by additional follow-up. The doses administered were 300 mg for each flavonoid, three times a day initially, then gradually reduced. Another study confirmed the efficacy of the micronized flavonoid fraction, composed of 90% diosmin and 10% hesperidin, in reducing edema and promoting the healing of venous ulcers. These clinical studies clearly illustrate the potential of bioflavonoids as a promising treatment to improve the symptoms of chronic venous insufficiency. It should be noted that Daflon, a medication composed of bioflavonoids such as hesperidin, is frequently used in the treatment of venous insufficiency and hemorrhoids.

Posologie

posologieOral

posologie500 - 1000 mg


Synergies


Metabolic syndrome
✪✪✪✪✪

Citrus bioflavonoids, particularly hesperidin, have shown significant beneficial effects on cardiovascular health across various clinical trials. Hesperidin, administered at 500 mg per day in capsule form for 12 weeks, has demonstrated an ability to reduce fasting glucose levels in patients with metabolic syndrome, highlighting its potential in managing cardiovascular risk factors. In addition, daily consumption of 500 mL of orange juice enriched with hesperidin resulted in a notable reduction in insulin and the HOMA-IR index, confirming its antidiabetic properties. A meta-analysis conducted by Khorasanian et al. highlighted significant beneficial effects of hesperidin on key parameters such as triglyceride levels, total cholesterol, LDL cholesterol, tumor necrosis factor-alpha, and systolic blood pressure. The results suggest that effective supplementation dosages are around 1,000 mg per day, with supplementation durations longer than six weeks needed to favorably influence fasting glucose and more than eight weeks for insulin levels.

Posologie

posologieOral

posologie500 - 1000 mg

duration12 weeks


Properties


Antioxidant

full-leaffull-leaffull-leaffull-leaf

Citrus bioflavonoids, thanks to their exceptional antioxidant properties, play an important role in combating oxidative stress and cellular aging. These natural compounds act in multiple ways: they neutralize various free radicals such as hydroxyl and superoxide radicals, prevent lipid peroxidation, and chelate metals, thereby preventing metal-catalyzed oxidation. Their free-radical scavenging activity is mainly due to their ability to donate hydrogen atoms, thanks to the phenolic groups they possess, allowing stabilization of radicals on their molecular structure.nnResearch shows that orange juices rich in flavonoids and other polyphenols offer significant antioxidant capacity, suggesting that daily intake of orange juice could provide additional protection against oxidation.nn


Anti-inflammatory

full-leaffull-leaffull-leafempty-leaf

Citrus bioflavonoids, notably hesperidin and nobiletin, have demonstrated a notable capacity to modulate immune and inflammatory responses. Their anti-inflammatory effects can be attributed to the inhibition of key regulatory enzymes such as protein kinase C, phosphodiesterase, phospholipase, lipoxygenase and cyclooxygenase, which play a crucial role in the formation of biological mediators that activate endothelial cells and other cells specialized in inflammation. For example, hesperidin can reduce inflammation in cases of pleurisy (a medical condition characterized by inflammation of the pleura, a thin membrane surrounding the lungs and lining the inner wall of the thoracic cavity), decreasing the fluid and the number of white blood cells involved. Nobiletin, for its part, has shown a selective effect in downregulating the expression of cyclooxygenase-2 without affecting cyclooxygenase-1, and has reduced the production of prostaglandin E2 and the expression of pro-inflammatory cytokines.


Venotonic

full-leaffull-leaffull-leafempty-leaf

Bioflavonoids, including hesperidin, significantly improve venous health through several interdependent mechanisms that have been extensively documented in clinical and experimental studies. These natural compounds act mainly by strengthening venous tone and reducing venous stasis, which is crucial for preventing and managing the symptoms of chronic venous insufficiency (CVI). Hesperidin plays a vital role in modulating inflammation and in protecting venous structures from damage. It inhibits the synthesis of prostaglandins and free radicals, reduces microvascular leakage induced by bradykinin (a vasodilator peptide that helps increase blood flow), and limits leukocyte activation and migration. These actions decrease leukocyte infiltration and the tissue damage associated with CVI, thereby facilitating the healing of venous ulcers and reducing edema. In clinical practice, the use of hesperidin has shown an improvement in endothelial function, which is essential for maintaining the integrity of blood vessels and preventing vascular complications. Hesperidin supplementation could therefore represent a promising therapeutic approach for the treatment of chronic venous insufficiency.

Usages associés

Venous insufficiency

Anticancer

full-leaffull-leafempty-leafempty-leaf

Citrus bioflavonoids, through their antimutagenic effects, significantly inhibit tumor development and cell proliferation. They protect DNA from damage caused by UV radiation and neutralize free radicals that can induce mutations near DNA. In addition, flavonoids such as naringin and nobiletin have demonstrated the ability to inhibit enzymes involved in tumor promotion and to reduce the expression of certain pro-inflammatory genes, thereby limiting the development and progression of cancer cells. Studies have revealed that citrus flavonoids can delay tumor development, notably by positively influencing cellular metabolism and by inhibiting key metabolic pathways in tumor cells. They also exert a direct cytotoxic effect on various types of cancer cells by inducing apoptosis (programmed cell death) without affecting surrounding healthy cells.


Cardiovascular

full-leaffull-leafempty-leafempty-leaf

Citrus flavonoids, including hesperidin, naringin, and nobiletin, have demonstrated a wide range of beneficial effects on cardiovascular and metabolic health, in part due to their potent antioxidant activity, their ability to improve glucose tolerance and insulin sensitivity, and their modulatory effect on lipid metabolism and adipocyte differentiation. In addition, they contribute to the suppression of inflammation and apoptosis and to the improvement of endothelial function, a key factor in the prevention of cardiovascular disease. Hesperidin, for example, acts by inhibiting phosphodiesterase and increasing intracellular cAMP, which leads to a reduction in the production of inflammatory prostaglandins and thromboxane B2. This action is crucial for its anti-inflammatory effects and for reducing platelet aggregation, helping to prevent thrombus formation. Preliminary clinical research has shown that daily intake of 500 mg of hesperidin increases flow-mediated dilation, indicating an improvement in endothelial function in patients with metabolic syndrome, in addition to reducing inflammatory biomarkers such as C-reactive protein.

Usages associés

Atherosclerosis, Metabolic syndrome

Antimicrobial

full-leafempty-leafempty-leafempty-leaf

Studies have shown that bioflavonoids possess significant antimicrobial activity, particularly against various viruses and bacteria. This activity is mainly due to non-glycosylated compounds, and the presence of a hydroxyl group at position 3 is essential for antiviral activity. 40-hydroxy-3-methoxy flavones have demonstrated efficacy against rhinoviruses and polioviruses. The structure of these flavonoids, notably multiple substitution on the A ring, is crucial for their superior antiviral activity. Quercetin and hesperidin, for example, inhibit the replication of several viruses, including herpes simplex and poliovirus. However, not all flavonoids exert this activity; grapefruit naringenin, for example, has not shown this efficacy.


Neurological

full-leafempty-leafempty-leafempty-leaf

Bioflavonoids, such as hesperidin, demonstrate notable neuroprotective potential, particularly relevant for neurodegenerative disorders like Parkinson's and Alzheimer's disease. Hesperidin protects against hydrogen peroxide-induced neurotoxicity in a laboratory model. It acts by attenuating behavioral alterations, oxidative stress, and dysfunctions of mitochondrial enzyme complexes, possibly via a nitric oxide-related mechanism. In the context of Parkinson's disease, hesperidin improves vascular tone and reduces stasis, contributing to the normalization of capillary permeability and lymphatic drainage, which is crucial for modulating inflammatory responses in the brain. It also inhibits phosphodiesterase, thereby increasing intracellular cAMP, which reduces the production of inflammatory prostaglandins and thromboxane, key molecules in the inflammatory and coagulation processes associated with neurodegeneration. Furthermore, hesperidin has shown positive effects on endothelial function, which is essential for preventing cardiovascular complications often associated with neurodegenerative diseases. It also helps modulate leukocyte gene expression, which could contribute to its anti-atherogenic and cardioprotective effects, thereby reducing the risk of progression of neurodegenerative diseases. By regulating glutathione (GSH) levels, glutathione peroxidase (GPx) and catalase activities, and preventing the formation of reactive oxygen species, hesperidin could help prevent the depletion of dopamine and its metabolites, which is critical in diseases such as Parkinson's.


Safe dosage

Adult: 500 mg - 1000 mg

Bioflavonoids are consumed safely up to 1300 mg, according to studies, for 3 months.nn


Interactions

Médicaments

Celiprolol: weak interaction

Animal research shows that the use of hesperidin may reduce the plasma area under the curve of celiprolol by up to 75%.

Diltiazem: weak interaction

Animal research suggests that hesperidin may improve the bioavailability of diltiazem.

Antihypertensive: weak interaction

Some clinical and animal research shows that hesperidin may lower blood pressure.

Antiplatelet agents/Anticoagulants: weak interaction

Animal research suggests that bioflavonoids may have antiplatelet activity.

Plantes ou autres actifs

Bioflavonoids: moderate interaction

Some studies suggest that bioflavonoids improve the absorption of vitamin C.


Precautions

Pregnant women: use with caution

Consumption during the third trimester of pregnancy of a combination of hesperidin and diosmin (100 mg) for 30 days does not seem to pose safety concerns for the pregnant woman.nn

Breastfeeding women: use with caution

Consumption during breastfeeding of a combination of hesperidin and diosmin (100 mg) does not appear to affect the infant's growth or feeding.nn